[童年自限焦点] 儿童自限焦点
Bolívar F Quito-Betancourt1, Gabriela Reyes Valenzuela2
1Hospital Monte Sinaí, INTUS Instituto de Neurología y Psicología Infantil del Austro, Cuenca, Ecuador.
Medicina
|September 15, 2023
概括
儿童自限焦点 (SELFEs) 是一种常见的儿科综合征. 新的定义标准化了诊断,远离"良性"和"异常",以更好地反映患者的并发症和特定的分类.
科学领域:
- 儿科神经学 儿科神经学
- 临床病学 临床病学
- 鼻科学和分类学与分类学
背景情况:
- 儿童自限焦点 (SELFEs) 是儿科患者中最常见的电临床综合征.
- 这些综合征表现出与年龄相关的特征性发病和缓解模式.
- 以前的术语,如"良性"和"无病性",正在修订,以提高诊断准确性和承认并发性疾病.
研究的目的:
- 概述由ILAE鼻学和定义工作组 (2022) 建立的童年自限焦点 (SELFEs) 的更新定义和诊断标准.
- 为了标准化这些流行儿科综合征的诊断.
- 澄清术语的适当使用,区分SELFEs与异常性泛性,并承认相关的并发症.
主要方法:
- 对SELFEs的2022年ILAE名义和定义工作组标准的审查和采用.
- 在SELFEs分类中包含的关键综合征的识别:具有中尖的自我限制性,具有自主性的自我限制性,儿童尾视觉和光敏感的尾叶.
- 建立标准化诊断的警报和排除标准.
主要成果:
- 国际抗联盟 (ILAE) 已经定义了"自限儿童焦点" (SELFEs),以标准化诊断.
- 针对SELFEs,已经建立了特定的诊断标准,包括警报和排除标准.
- 由于潜在的并发症,该分类现在不包括"良性"一词,并仅为Idiopathic Generalized Epilepsies保留"无病性".
结论:
- 更新的SELFEs定义和分类为诊断这些常见的儿科综合征提供了一个标准化的框架.
- 远离"良性"一词承认了与这些疾病相关的复杂性和潜在的并发症.
- 精确的术语对于准确的诊断和管理至关重要,将SELFEs与其他类型的症 (如异常性泛性) 区分开来.
更多相关视频
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
20.4K
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
885
相关概念视频
01:13Seizures: Classification
406
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
406
01:24Arteries of the Lower Limbs
212
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
212
01:14Antiepileptic Drugs: Glutamate Antagonists
418
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
418
01:08Antiepileptic Drugs: Sodium Channel Blockers
652
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
652
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
339
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
339
01:17Antiepileptic Drugs: Calcium Channel Blockers
445
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
445